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Diabetic macular edema (DME) is the most 
common cause of reduced vision in diabetic 
patients. About one in four diabetic patients has a 
risk of developing DME during a lifetime1. Most 
frequently used follow up test for macular diseases 
are Amsler grid test, 10/2 visual field testing2. 
Optical cohorent tomography (OCT) is a new retinal 
imagining technique that produces cross-sectional 
images of the retina and is frequently used in DME3. 
Photocoagulation was established as an effective 
treatment in the 1980s and is still being one of the 
options for DME4. Other treatment modalities which 
have emerged in the more recent years are 
intravitreal steroids, anti-vascular endothelial growth 
factor (VEGF) drugs and the release of vitreoretinal 
traction by means of surgical pars plana vitrectomy. 
Generally, edema is defined as an abnormal 
accumulation of water in a tissue. Starling in 1896 
defined the forces that transport water between the 
vascular space and tissue interstitial space. The 
forces are hydrostatic and osmotic. In homeostasis, 
the hydrostatic pressure gradient and the osmotic 
pressure gradients between blood vessel and tissue 
are balanced. But this balance can be disturbed if 
either pressure gradient is changed. Either an 
increase in the hydrostatic pressure gradient or a 
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ABSTRACT 
There are multiple different treatment options of diabetic 
macular edema. Therefore it is important to understand 
the physiological mechanism of these treatment 
modalities when deciding the appropriate combination of 
treatment options. We herein present a brief review of 
available treatment options of diabetic macular edema 
with particular consideration of the mechanisms of action. 
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ÖZET
Diyabetik maküla ödeminde tedavi seçenekleri fazladır. 
Bu yüzden diyabetik maküla ödemi tedavi seçenekleri 
arasında doğru kombinasyona karar verirken altta yatan 
fizyolojik mekanizmaları anlamak önemlidir. Burada altta 
yatan fizyolojik mekanizmaları göz önünde bulundurarak 
diyabetik maküla ödeminin tedavi seçeneklerini kısaca 
gözden geçirdik. 
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Due to the concentration of albumin, the 
osmotic pressure in blood is higher than that in the 
tissue interstitial space and this pulls water back 
from the tissue interstitial space into the blood 
circulation and reduces edema. DME is associated 
with increased leakage of the macular capillaries, as 
is seen on fluorescein angiography and 
fluorophotometry5. The physiological importance of 
capillary leakage is the leakage of macromolecules, 
predominantly albumin, not just water from the blood 
into the tissue interstitial space. The accumulation of 
albumin in the tissue interstitial space increases the 
osmotic pressure in the tissue and reduces the 
osmotic pressure difference between the interstitial 
space and blood. The smaller osmotic pressure 
gradient is less effective in pulling water back to the 
blood stream from the tissue interstitial space and 
consequently water accumulates in the tissue 
interstitial space and edema develops. VEGF is very 
effective in increasing the permeability of retinal 
capillaries and reduces the osmotic gradient that 
should pull water back into capillaries. VEGF is a 
growth factor for new blood vessel formation. The 
newly-formed blood vessels are very leaky and this 
results in edema. Therefore anti-VEGF agents are 
used in the treatment. 
Treatments Available that Increase Osmotic 
Pressure Gradient 
a) Photocoagulation 
Vascular endothelial growth factor production is 
controlled by oxygen tension in the tissue; the 
production of VEGF is induced by hypoxia. It is 
shown that breathing pure oxygen reduces DME6. 
Retinal laser photocoagulation also raises the 
oxygen tension in the retina and reduces hypoxia. 
This is because the destruction of the 
photoreceptors located in the peripheral retina 
reduces the oxygen consumption of the retina 
overall and allows an oxygen flux to diffuse from the 
choroid through the glial laser scar into the inner 
retina in the macular area without being consumed 
by the photoreceptors located in the peripheral 
retina. This increases the oxygen tension in the 
inner retina and thus decreases the VEGF 
production. 
b) Vitrectomy 
In vitrectomy, the viscous vitreous gel is 
replaced by low viscosity saline, and that allows 
faster transport of other molecules, such as VEGF, 
which can diffuse more readily from the retina into 
the vitreous cavity. This reduces the VEGF 
concentration in the retina7. Reducing VEGF 
concentration in the retina reduces, in turn, capillary 
leakage of high molecular weight proteins such as 
albumin. 
c) Anti-VEGF treatment 
The injection of VEGF antibodies into the 
vitreous cavity, such as bevacizumab and 
ranibizumab, has similar consequences to 
vitrectomy, because effective free VEGF 
concentration is reduced. Free VEGF in the vitreous 
gel is bound by the antibody, thus lowering the 
concentration of free VEGF in the vitreous cavity 
and increasing the diffusion and clearance of VEGF 
from the retina, thus lowering its concentration. In 
addition, ranibizumab penetrates deeper into the 
retina and also binds VEGF in the retina itself. 
d) Steroids 
Corticosteroids suppress inflammation by 
inhibiting multiple inflammatory cytokines, resulting 
in decreased migration of inflammatory cells and 
capillary leakage. Moreover, corticosteroids may 
also have an inhibitory effect on the VEGF 
pathway8. New intravitreal implants that provide 
sustained release of steroids at therapeutic levels 
for 6 months to 3 years are currently being 
evaluated for the treatment of DME. 
Treatments Available that Reduce 
Hydrostatic Pressure Gradient 
a) Arterial Blood Pressure 
Arterial hypertension is a risk factor for DME. It 
is also established that reducing arterial blood 
pressure lowers the hydrostatic powers that push 
water out of capilleries and therefore reduces 
DME1. 
b) Vitreoretinal Traction 
Vitreoretinal traction reduces interstitial tissue 
hydrostatic pressure and therefore the hydrostatic 
pressure gradient causing water to go out of the 
capillaries increases. Procedures like intracapsular 
cataract extraction as an example produces loss 
and therefore vitrous traction and complications like 
cystiod macular edema more frequently seen9. It is 
known that releasing any of the vitreoretinal 
tractional forces by means of vitrectomy, improves 
resolution of the macular edema and restores visual 
acuity10-12. 
c) Vasoconstriction 
Retinal laser photocoagulation and vitrectomy 
increase the oxygen tension in the inner retina. 
Increased oxygen tension results in an 
autoregulatory vasoconstriction, where arterioles 
constrict and their resistance increases. This results 
in a decrease in hydrostatic pressure in capillaries 
and a decrease in the hydrostatic gradient between 
the vascular compartment and tissue interstitial 
space, thus reducing water flux from vessel to tissue 
and decreasing edema. Vasoconstriction in the 
retina is seen not only following laser treatment but 
also following intravitreal triamcinolone and 
bevacizumab injections. 
CONCLUSİON 
The pathogenesis of macular edema includes 
multiple insults to normal retinal function and there 
are multiple treatment options available, but still as a 
first step we must take the main physiologic 
mechanisims into consideration while deciding on 
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